Proliferation Risk — One Instrument Is Simple, Multiple Are Not
In the early stages of a company’s financing lifecycle, the primary objective is often the preservation of momentum. Founders frequently turn to Convertible Notes or Simple Agreements for Future Equity (SAFEs) to secure capital quickly while bypassing the friction of a formal valuation negotiation. However, the structural reality of venture finance is that these instruments rarely exist in isolation. While a single SAFE or note is indeed a streamlined document, the accumulation of multiple instruments over successive seed or bridge rounds introduces a layer of structural complexity and misalignment that can threaten the long-term fundability of the business.
As established in earlier posts in this series, individual instruments are designed to allocate risk through specific pricing mechanics like valuation caps and discounts. This post focuses on the cumulative consequences that emerge when these instruments “stack” on a capitalization table over time, transforming what was meant to be a simple shortcut into a rigid structural constraint.
Why are multiple SAFEs risky?
Multiple SAFEs compound dilution, fragment investor incentives, and often create cap-table overhang that must be resolved before a Series A can close.
The Silent Compounding of Structural Risk
Proliferation risk is fundamentally a structural issue, not merely a documentation or administrative burden. When a company enters a cycle of “runaway serial seed” rounds, it accumulates a series of promises to issue future equity under different conditions. Because these instruments often defer the valuation discussion, they create a recursive loop of uncertainty regarding actual ownership percentages.
This complexity compounds silently between rounds. In the current market, Y Combinator’s “post-money” SAFE has become a common standard, but it carries a specific structural trap: common stock absorbs all dilution from any subsequently issued SAFEs or convertible notes until a priced equity round occurs. In this framework, early SAFE holders are fully protected from the dilutive impact of later seed-stage checks, meaning the founders’ ownership is eroded incrementally and exclusively. This creates a “cap table grab” where the math of the round is only fully revealed when it “comes crashing down” during a Series A financing.
Fragmented Incentives and Leverage Reshaping
Stacked instruments also fragment the incentives of your stakeholders. When you have multiple series of notes or SAFEs with divergent valuation caps, your investors no longer view the company’s progress through the same lens. An investor with a very low cap may be structurally incentivized to favor a lower Series A valuation to maximize their ownership, while a later investor with a higher cap may prioritize a higher valuation to avoid their own dilution. This divergence can lead to negotiation friction during the due diligence phase of an institutional round.
Furthermore, the proliferation of side letters and specific rights—such as Most Favored Nation (MFN) provisions or pro rata rights—reshapes the leverage in the relationship. An MFN provision allows early investors to adopt the more favorable terms of later instruments, creating a moving target for the company’s eventual capitalization. Pro rata rights, when granted to a large number of small seed investors, add significant administrative hassle and legal costs to later financings. Chasing down dozens of signatures from diffuse angel investors to approve a merger or a new financing round is a precarious position for any founder.
The Rigidity of “Speed Today”
The marketing narrative for convertible instruments emphasizes that they are “fast and cheap”. However, this speed often converts into rigidity later in the company’s life. Because investors rely on pattern recognition and precedent, the terms granted in an early “simple” SAFE often become the immovable reference points for later institutional VCs. Institutional leads may refuse to fund until the “messy” cap table created by stacked instruments is cleaned up, often requiring founders to renegotiate with their earliest supporters at their own personal economic expense.
Narrative Scenarios: Proliferation in Practice
To illustrate how these structural forces manifest, consider the following narrative scenarios:
- The Cumulative Dilution Trap
A founder raised three separate tranches of post-money SAFEs over eighteen months to maintain a high growth rate without the distraction of a priced round. Each SAFE had a slightly higher valuation cap, which the founder perceived as progress. However, because the post-money SAFE structure protects investors from dilution caused by later SAFEs, the founders’ common stock absorbed the entirety of the dilution for all three rounds. By the time a Series A lead investor performed a “shadow” conversion analysis, the founders discovered they had already committed 30% of the company before the new round even began. The “speed” of the seed stage resulted in a structural overhang that left the founders with significantly less leverage to negotiate their own ongoing vesting and incentive terms.
- The Minority Veto Gridlock
In another situation, a startup issued several small convertible notes to twenty different angel investors during a difficult market dip. To close the round, the founder granted Most Favored Nation rights to the group and a side letter allowing a majority of the noteholders to veto any amendments to the conversion price. Two years later, the company secured a Series A term sheet from a top-tier firm, but the new lead insisted on converting the notes into a “shadow series” with lower liquidation preferences to ensure a clean cap table. A small group of original noteholders, representing only a fraction of the total capital but holding disproportionate structural leverage through the earlier side letter, blocked the conversion to force a payout. The accumulation of these small, early instruments created a “fiduciary sandwich” that nearly derailed the company’s first major institutional financing.
Conclusion: Instrument as Strategy
One instrument is a tool; multiple instruments are a capitalization strategy that must be managed with a view toward the eventual priced round. The structural consequences of stacking notes and SAFEs are often hidden by the apparent simplicity of the individual documents, yet they compound into the precedents that define your company’s future.
The accumulation of convertible securities is a highly context-specific risk that requires rigorous modeling of “as-converted” outcomes before leverage is fully committed. These structural dynamics are rarely visible in standard templates and benefit from an experienced review to identify where fragmented incentives or side-letter proliferation may be quietly constraining your future options. If you are managing multiple series of notes or SAFEs and wish to perform a strategic review of your cap table before your next major financing, I invite you to book a consultation.
Advanced Mechanics: How SAFEs, Notes, and Caps Actually Dilute Ownership.